➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Johnson and Johnson
Colorcon
Dow
Baxter

Last Updated: January 28, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Fallypride

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Fallypride?

Fallypride is an investigational drug.

There have been 14 clinical trials for Fallypride. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2005.

The most common disease conditions in clinical trials are Schizophrenia, Alcoholism, and Depressive Disorder, Treatment-Resistant. The leading clinical trial sponsors are Vanderbilt University Medical Center, University of California, Irvine, and Janssen-Cilag G.m.b.H.

Recent Clinical Trials for Fallypride
TitleSponsorPhase
Dopaminergic Dysfunction in Late-Life DepressionColumbia UniversityPhase 2
Dopaminergic Dysfunction in Late-Life DepressionEmory UniversityPhase 2
Dopaminergic Dysfunction in Late-Life DepressionVanderbilt University Medical CenterPhase 2

See all Fallypride clinical trials

Clinical Trial Summary for Fallypride

Top disease conditions for Fallypride
Top clinical trial sponsors for Fallypride

See all Fallypride clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Johnson and Johnson
Colorcon
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.